Zycubo 2.9 mg/1
copper histidinate · INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION · Sentynl Therapeutics, Inc.
Zycubo is a injection, powder, lyophilized, for solution containing copper histidinate at 2.9 mg/1, taken subcutaneous. Manufactured by Sentynl Therapeutics, Inc..
Key Facts
- Brand Name
- Zycubo
- Generic Name
- copper histidinate
- NDC Code (Product)
42358-329- Manufacturer
- Sentynl Therapeutics, Inc.
- Strength
- 2.9 mg/1
- Dosage Form
- INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION
- Route
- SUBCUTANEOUS
- Marketing Status
- Application #
- NDA211241
- Marketing Start
- 01/12/2026
Recall History
No Recall HistoryFrequently Asked Questions
What is Zycubo used for?
Zycubo contains copper histidinate. It is a injection, powder, lyophilized, for solution taken subcutaneous. Consult your doctor for specific uses.
Is Zycubo a controlled substance?
Zycubo is not classified as a controlled substance by the DEA.
What is the generic name for Zycubo?
The generic name for Zycubo is copper histidinate. There are no other listed brand versions of copper histidinate.
What is the NDC code for Zycubo 2.9 mg/1?
The NDC (National Drug Code) for Zycubo 2.9 mg/1 is 42358-329, listed by Sentynl Therapeutics, Inc..
Not medical advice. Always consult your doctor or pharmacist before making any medication decisions.
Data from openFDA · Public domain (CC0 1.0)